Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) is expected to be releasing its earnings data on Tuesday, March 4th. Analysts expect Bayer Aktiengesellschaft to post earnings of $0.28 per share and revenue of $11.38 billion for the quarter. Individual that are interested in registering for the company's earnings conference call can do so using this link.
Bayer Aktiengesellschaft Price Performance
Shares of Bayer Aktiengesellschaft stock traded down $0.01 during trading on Friday, hitting $5.93. 1,101,858 shares of the company's stock traded hands, compared to its average volume of 1,030,496. The firm's fifty day moving average price is $5.38 and its 200 day moving average price is $6.32. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.32 and a quick ratio of 0.81. The company has a market cap of $23.30 billion, a PE ratio of -22.81 and a beta of 1.04. Bayer Aktiengesellschaft has a twelve month low of $4.79 and a twelve month high of $8.58.
About Bayer Aktiengesellschaft
(
Get Free Report)
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Further Reading

Before you consider Bayer Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.
While Bayer Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.